Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05985291 · ClinicalTrials.gov registry record
BurstDR Stimulation for Painful Diabetic Neuropathy
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 6
- Enrollment target
NCT05985291 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 6 participants.
The verdict
NCT05985291 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This study aims to demonstrate treatment outcomes of Painful Diabetic Neuropathy (PDN) patients treated with BurstDRTM Spinal Cord Dorsal Column Stimulator (SCS) along with conservative medical management per standard of care.
Interventions
- COMBINATION_PRODUCT SCS in combination with CMM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-07-03 |
| Est. Completion | 2025-10-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05985291
The ClinicalTrials.gov registry entry for NCT05985291 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SCS in combination with CMM is the first listed.
NCT05985291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05985291 about?
NCT05985291 is a clinical study titled "BurstDR Stimulation for Painful Diabetic Neuropathy". This study aims to demonstrate treatment outcomes of Painful Diabetic Neuropathy (PDN) patients treated with BurstDRTM Spinal Cord Dorsal Column Stimulator (SCS) along with conservative medical management per standard of care.
What is the current status of trial NCT05985291?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2023-07-03. Estimated completion is 2025-10-06.
What interventions are being tested in trial NCT05985291?
The interventions under investigation include: SCS in combination with CMM (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05985291?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.